Feedback offers Bleepa for COVID-19 use

Feedback (LON: FDBK) is offering its Bleepa medical imaging communications platform to help with COVID-19. Hospitals will be able to use it for free.

Bleepa was launched last July. It can be used to transmit encrypted data between a hospital and a clinician’s own device when they are away from the hospital. Images, such as x-rays, CT scans and ultrasound scans can be sent.

In the case of COVID-19, images of the lungs of patients can be transmitted. The image quality means that important decisions can be made from these images.

Bleepa uses Feedback’s Cadran picture archiving and communications system. There is also an encrypted messaging function.

Bleepa is the main focus for Feedback and it offers the potential for significant recurring revenues.

AIM-quoted Feedback secured the first pilot study for Bleepa with The Pennine Acute Hospitals NHS Trust, which has been using Bleepa for respiratory requests. This pilot was near to completion, but it has been suspended for the time being.


One of the attractions of Bleepa is that it can be used by clinicians that are self-isolating. They can continue to help with diagnosis. The whole team can be in different locations and still be able to work together.

There has been a significant increase in chest x-rays and CT scans. These can be assessed via Bleepa and there is no concern about security.

This will help to make clinicians aware of the effectiveness of Bleepa and how it can be helpful at any time.

The Feedback share price has been highly volatile. There was a jump in the share price, but it fell back to 0.65p.